CloudMD Software & Services Inc. (TSXV: DOC, OTC: DOCRF,
Frankfurt: 6PH) (the “
Company” or
“
CloudMD”), a healthcare technology company
transforming the delivery of care, is excited to announce an
expanded partnership with Apotex, a Canadian-based global
pharmaceutical company, to provide Apotex Latinoamérica with its
flagship IMD Health digital education resource platform to support
doctors, patients and individuals in Latin America and provide
access to its robust database of trusted health educational
resources. The IMD platform will be available in Mexico, Costa
Rica, Panama and Nicaragua.
For the last 25 years, Latin America has been a
key focus area for Apotex with the goal of improving the health and
well-being of patients in the region by providing affordable,
innovative, and high-quality solutions.
The IMD educational platform is Canada’s largest
digital education health database with over 5,600 medical topics
(anatomy, conditions and procedures) in a simple-to-use format with
over 110,000 resources in a variety of formats including articles,
images, infographics and short videos, in several languages
(including Spanish). The content is customized by audience, so
healthcare professionals or patients can learn more valuable
information about an illness, treatment, or other healthcare
topics.
Together, CloudMD and Apotex Latinoamérica have
partnered to provide better access to healthcare resources for
doctors and patients in Latin America. The partnership focuses on
two core platforms: (1) an integration into a Apotex-operated
physician web portal and, (2) integration into a public facing web
portal. CloudMD’s educational platform will provide access to
trusted, peer-reviewed healthcare resources that will assist and
support doctors and patients throughout their care journey. The
platform has developed Spanish as a core language option on the
offering which provides further opportunities for global
expansion.
“Over the last 25 years, we have been committed
to improving the health and well-being of patients and families in
Latin America. Our Partnership with CloudMD to adopt its IMD Health
education platform reinforces our commitment to provide trusted
healthcare resources to support and educate individuals through
their health journeys. Trusted health information is essential to
patient health, and we are excited to support our doctors, patients
and the general public with access to this credible digital health
information,” commented Américo García, Vice-President and
General Manager, Apotex Latinoamérica.
Dr. Essam Hamza, CEO of CloudMD
commented, “We are excited to announce an expansion of our
partnership with Apotex into Latin America. Our IMD Health
education platform has a robust database, and we feel very
fortunate to be able to provide credible, trusted healthcare
resources to practitioners and patients to support their health
needs.”
About Apotex Inc.
Apotex Inc. is a proudly Canadian, global
pharmaceutical company that produces high-quality, affordable
medicines for patients around the world. Apotex employs almost
8,000 people worldwide in manufacturing, R&D, and commercial
operations. Apotex Inc. exports to more than 100 countries
and territories and operates in more than 45 countries, with a
significant presence in Canada, the US, Mexico, and India. Through
vertical integration, Apotex is comprised of multiple divisions and
affiliates including Apotex Inc., focused on generics; Apotex
Corp., an affiliate of Apotex Inc. which markets and sells product
in the United States; Apobiologix, a division of Apotex Inc.
focused on biosimilar development; Aveva, an affiliate of Apotex
Inc. fully integrated global developer and manufacturer of complete
transdermal solutions; Apotex Consumer Products, a division of
Apotex Inc. focused on brand name products; and Global Active
Pharmaceutical Ingredients (GAPI), a division of Apotex Inc.
focused on the manufacturing of active pharmaceutical ingredients
(API) for Apotex and third parties. For more information
visit: www.apotex.com
For more information, contact Jordan Berman, VP
Global Corporate Affairs jberman@apotex.com
About CloudMD Software &
Services
CloudMD is transforming the delivery of
healthcare using technology and by providing a patient-centric
approach, with an emphasis on continuity of care. By leveraging
healthcare technology, the Company is building one, connected
platform that addresses all points of a patient’s healthcare
journey and provides better access to care and improved outcomes.
Through CloudMD’s proprietary technology, the Company delivers
quality healthcare through a holistic offering including hybrid
primary care clinics, specialist care, telemedicine, mental health
support, healthcare navigation, educational resources, and
artificial intelligence (AI). CloudMD’s Enterprise Health Solutions
Division includes the leading Student Assistance Program and one of
the top 4 Employee Assistance Programs in Canada and offers one
comprehensive, digitally connected platform for educational
institutions, corporations, insurers, and advisors to better manage
the health and wellness of their students, employees, and
customers.
CloudMD currently services a combined ecosystem
of over 7,000 psychiatrists, approximately 4,500 therapists and
counsellors, approximately 4,000 psychologists, over 22,000 family
physicians, over 34,000 medical specialists, over 1,500 allied
health professionals, over 500 clinics, and over 5 million
individuals across North America. For more information
visit: https://investors.cloudmd.ca.
FOR ADDITIONAL INFORMATION, CONTACT:
Julia BeckerVP, Investor
Relationsjulia@cloudmd.ca(604) 785-0850
Forward Looking Statements
This news release contains forward-looking
statements that are based on CloudMD’s expectations, estimates and
projections regarding its business and the economic environment in
which it operates, including with respect to its business plans.
Although CloudMD believes the expectations expressed in such
forward-looking statements are based on reasonable assumptions,
such statements are not guarantees of future performance and
involve risks and uncertainties that are difficult to control or
predict. Therefore, actual outcomes and results may differ
materially from those expressed in these forward-looking statements
and readers should not place undue reliance on such statements.
These forward-looking statements speak only as of the date on which
they are made, and CloudMD undertakes no obligation to update them
publicly to reflect new information or the occurrence of future
events or circumstances, unless otherwise required to do so by
law.
The TSX Venture Exchange does not accept
responsibility for the adequacy or accuracy of this release.
CloudMD Software & Servi... (TSXV:DOC)
Historical Stock Chart
From Mar 2024 to Apr 2024
CloudMD Software & Servi... (TSXV:DOC)
Historical Stock Chart
From Apr 2023 to Apr 2024